“HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer

BACKGROUND: Pancreatic cancer has a dismal prognosis with 5-year overall survival rate of around 5%. Although surgery is still the best option in operable cases, majority of the patients who present in locally advanced stages are deemed inoperable. Novel approaches are therefore needed for the manag...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Radiat Oncol
Main Authors: Datta, Niloy Ranjan, Pestalozzi, Bernhard, Clavien, Pierre-Alain, Siebenhüner, Alexander, Puric, Emsad, Khan, Shaka, Mamot, Christoph, Riesterer, Oliver, Knuchel, Jürg, Reiner, Cäcilia Sophie, Bodis, Stephan
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698973/
https://ncbi.nlm.nih.gov/pubmed/29162142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0923-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares